In in vivo preclinical studies, it has been reported that IGF1 messenger levels are lower in the liver tumour tissue than in the tumour-surrounding tissue or healthy liver tissue of mice harbouring HCC[97]. This evidence concerns the gene IGF1 and neoplasm.